Associate Director - Central Automation at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, ManufacturingIndustries

Requirements

Bachelor’s Degree in Engineering or Automation related field
Minimum of 5 years experience in a manufacturing environment
Technical competence in engineering, specifically automation and data architecture (Data Historians/LIFT/Database Management/PLCs/HMIs/DCS/Building Management Systems)
Experience in managing relationships with key vendors (Rockwell, B&R, etc.)

Responsibilities

Lead the staffing, training, and leadership of the Indianapolis Parenteral Manufacturing Central Automation group, comprising nine individuals, to support multiple process teams with delivery, support, and lifecycle management
Manage compliance for the infrastructure supporting all process teams' automation needs, including HMIs/Data Historians/PLCs/HMIs/DCS/Building Management Systems
Collaborate with Global Automation teams and parenteral networks to ensure filling lines comply with the latest supported software from a cybersecurity and data integrity perspective
Own and ensure compliance for IPM Automation Cybersecurity and Data Integrity
Influence the automation functional strategy across multiple plants within the IPM site
Support day-to-day engineering activities and plan for the 3-6 month horizon
Lead by example and coach others in safety, quality, engineering, and continuous improvement
Interact directly with regulatory agencies during site inspections

Skills

PLCs

HMIs

DCS

Data Historians

Building Management Systems

Cybersecurity

Data Integrity

Automation

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free